CAMK2G and catecholaminergic polymorphic ventricular tachycardia: For example, calcium/calmodulin-dependent kinase II (CaMKII), a calcium-sensing kinase regulator, contributes to arrhythmias and has been considered a prime therapeutic target for CPVT (73).